Denali initiates its biologics license application (BLA) application for the accelerated approval of Tividenofusp Alfa. Denali announces that it expects the BLA application to be completed by mid ...

Investors in Denali Therapeutics Inc (Symbol: DNLI) saw new options begin trading this week, for the December 19th expiration. One of the key inputs that goes into the price an option buyer is ...